nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Hypertensive crisis—Sorafenib—liver cancer	0.0521	0.0521	CcSEcCtD
Trospium—Hoarseness—Sorafenib—liver cancer	0.0329	0.0329	CcSEcCtD
Trospium—Dysphonia—Sorafenib—liver cancer	0.0176	0.0176	CcSEcCtD
Trospium—Endocrine disorder—Sorafenib—liver cancer	0.0175	0.0175	CcSEcCtD
Trospium—Rhabdomyolysis—Sorafenib—liver cancer	0.0164	0.0164	CcSEcCtD
Trospium—Supraventricular extrasystoles—Epirubicin—liver cancer	0.0144	0.0144	CcSEcCtD
Trospium—Influenza like illness—Sorafenib—liver cancer	0.0141	0.0141	CcSEcCtD
Trospium—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.0133	0.0133	CcSEcCtD
Trospium—Mouth ulceration—Sorafenib—liver cancer	0.0131	0.0131	CcSEcCtD
Trospium—Eczema—Sorafenib—liver cancer	0.0117	0.0117	CcSEcCtD
Trospium—Urine abnormality—Epirubicin—liver cancer	0.00966	0.00966	CcSEcCtD
Trospium—Dry skin—Sorafenib—liver cancer	0.00963	0.00963	CcSEcCtD
Trospium—Abdominal pain upper—Sorafenib—liver cancer	0.0096	0.0096	CcSEcCtD
Trospium—Breast disorder—Sorafenib—liver cancer	0.00949	0.00949	CcSEcCtD
Trospium—Nasopharyngitis—Sorafenib—liver cancer	0.0094	0.0094	CcSEcCtD
Trospium—Gastritis—Sorafenib—liver cancer	0.0093	0.0093	CcSEcCtD
Trospium—Urine analysis abnormal—Epirubicin—liver cancer	0.0091	0.0091	CcSEcCtD
Trospium—Urine abnormality—Doxorubicin—liver cancer	0.00894	0.00894	CcSEcCtD
Trospium—Abdominal discomfort—Sorafenib—liver cancer	0.00871	0.00871	CcSEcCtD
Trospium—Urine analysis abnormal—Doxorubicin—liver cancer	0.00842	0.00842	CcSEcCtD
Trospium—Infestation NOS—Sorafenib—liver cancer	0.0081	0.0081	CcSEcCtD
Trospium—Infestation—Sorafenib—liver cancer	0.0081	0.0081	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00803	0.00803	CcSEcCtD
Trospium—Stomatitis—Sorafenib—liver cancer	0.00789	0.00789	CcSEcCtD
Trospium—Urinary tract disorder—Sorafenib—liver cancer	0.00718	0.00718	CcSEcCtD
Trospium—Connective tissue disorder—Sorafenib—liver cancer	0.00714	0.00714	CcSEcCtD
Trospium—Urethral disorder—Sorafenib—liver cancer	0.00713	0.00713	CcSEcCtD
Trospium—Rash erythematous—Epirubicin—liver cancer	0.00699	0.00699	CcSEcCtD
Trospium—Erythema multiforme—Sorafenib—liver cancer	0.00687	0.00687	CcSEcCtD
Trospium—Flushing—Sorafenib—liver cancer	0.00675	0.00675	CcSEcCtD
Trospium—Cardiac disorder—Sorafenib—liver cancer	0.00675	0.00675	CcSEcCtD
Trospium—Angiopathy—Sorafenib—liver cancer	0.00659	0.00659	CcSEcCtD
Trospium—Mediastinal disorder—Sorafenib—liver cancer	0.00655	0.00655	CcSEcCtD
Trospium—Dysphonia—Epirubicin—liver cancer	0.0065	0.0065	CcSEcCtD
Trospium—Rash erythematous—Doxorubicin—liver cancer	0.00646	0.00646	CcSEcCtD
Trospium—Malnutrition—Sorafenib—liver cancer	0.00633	0.00633	CcSEcCtD
Trospium—Delirium—Epirubicin—liver cancer	0.00622	0.00622	CcSEcCtD
Trospium—Dysgeusia—Sorafenib—liver cancer	0.0062	0.0062	CcSEcCtD
Trospium—Muscle spasms—Sorafenib—liver cancer	0.00608	0.00608	CcSEcCtD
Trospium—Dysphonia—Doxorubicin—liver cancer	0.00602	0.00602	CcSEcCtD
Trospium—Angioedema—Sorafenib—liver cancer	0.00578	0.00578	CcSEcCtD
Trospium—Hyperuricaemia—Epirubicin—liver cancer	0.00577	0.00577	CcSEcCtD
Trospium—Delirium—Doxorubicin—liver cancer	0.00575	0.00575	CcSEcCtD
Trospium—Syncope—Sorafenib—liver cancer	0.00567	0.00567	CcSEcCtD
Trospium—Loss of consciousness—Sorafenib—liver cancer	0.00556	0.00556	CcSEcCtD
Trospium—Blood uric acid increased—Epirubicin—liver cancer	0.00545	0.00545	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00535	0.00535	CcSEcCtD
Trospium—Hyperuricaemia—Doxorubicin—liver cancer	0.00534	0.00534	CcSEcCtD
Trospium—Dermatitis contact—Epirubicin—liver cancer	0.00529	0.00529	CcSEcCtD
Trospium—Dry mouth—Sorafenib—liver cancer	0.00527	0.00527	CcSEcCtD
Trospium—Influenza like illness—Epirubicin—liver cancer	0.0052	0.0052	CcSEcCtD
Trospium—Anaphylactic shock—Sorafenib—liver cancer	0.00516	0.00516	CcSEcCtD
Trospium—Infection—Sorafenib—liver cancer	0.00513	0.00513	CcSEcCtD
Trospium—Shock—Sorafenib—liver cancer	0.00508	0.00508	CcSEcCtD
Trospium—Fluid retention—Epirubicin—liver cancer	0.00508	0.00508	CcSEcCtD
Trospium—Nervous system disorder—Sorafenib—liver cancer	0.00506	0.00506	CcSEcCtD
Trospium—Blood uric acid increased—Doxorubicin—liver cancer	0.00504	0.00504	CcSEcCtD
Trospium—Skin disorder—Sorafenib—liver cancer	0.00502	0.00502	CcSEcCtD
Trospium—Dry eye—Epirubicin—liver cancer	0.00494	0.00494	CcSEcCtD
Trospium—Dermatitis contact—Doxorubicin—liver cancer	0.00489	0.00489	CcSEcCtD
Trospium—Bladder pain—Epirubicin—liver cancer	0.00484	0.00484	CcSEcCtD
Trospium—Mouth ulceration—Epirubicin—liver cancer	0.00484	0.00484	CcSEcCtD
Trospium—Influenza like illness—Doxorubicin—liver cancer	0.00481	0.00481	CcSEcCtD
Trospium—Fluid retention—Doxorubicin—liver cancer	0.0047	0.0047	CcSEcCtD
Trospium—Abnormal vision—Epirubicin—liver cancer	0.00467	0.00467	CcSEcCtD
Trospium—Dry eye—Doxorubicin—liver cancer	0.00457	0.00457	CcSEcCtD
Trospium—Lymphadenopathy—Epirubicin—liver cancer	0.00455	0.00455	CcSEcCtD
Trospium—Dyspepsia—Sorafenib—liver cancer	0.00455	0.00455	CcSEcCtD
Trospium—Decreased appetite—Sorafenib—liver cancer	0.00449	0.00449	CcSEcCtD
Trospium—Mouth ulceration—Doxorubicin—liver cancer	0.00448	0.00448	CcSEcCtD
Trospium—Bladder pain—Doxorubicin—liver cancer	0.00448	0.00448	CcSEcCtD
Trospium—Gastrointestinal disorder—Sorafenib—liver cancer	0.00446	0.00446	CcSEcCtD
Trospium—Fatigue—Sorafenib—liver cancer	0.00445	0.00445	CcSEcCtD
Trospium—Constipation—Sorafenib—liver cancer	0.00442	0.00442	CcSEcCtD
Trospium—Eczema—Epirubicin—liver cancer	0.00432	0.00432	CcSEcCtD
Trospium—Abnormal vision—Doxorubicin—liver cancer	0.00432	0.00432	CcSEcCtD
Trospium—Eye pain—Epirubicin—liver cancer	0.0043	0.0043	CcSEcCtD
Trospium—Gastrointestinal pain—Sorafenib—liver cancer	0.00422	0.00422	CcSEcCtD
Trospium—Lymphadenopathy—Doxorubicin—liver cancer	0.00421	0.00421	CcSEcCtD
Trospium—Hot flush—Epirubicin—liver cancer	0.00415	0.00415	CcSEcCtD
Trospium—Menopausal symptoms—Epirubicin—liver cancer	0.00412	0.00412	CcSEcCtD
Trospium—Urticaria—Sorafenib—liver cancer	0.0041	0.0041	CcSEcCtD
Trospium—Abdominal pain—Sorafenib—liver cancer	0.00408	0.00408	CcSEcCtD
Trospium—Eczema—Doxorubicin—liver cancer	0.004	0.004	CcSEcCtD
Trospium—Eye pain—Doxorubicin—liver cancer	0.00398	0.00398	CcSEcCtD
Trospium—Hot flush—Doxorubicin—liver cancer	0.00384	0.00384	CcSEcCtD
Trospium—Migraine—Epirubicin—liver cancer	0.00382	0.00382	CcSEcCtD
Trospium—Menopausal symptoms—Doxorubicin—liver cancer	0.00381	0.00381	CcSEcCtD
Trospium—Asthenia—Sorafenib—liver cancer	0.00371	0.00371	CcSEcCtD
Trospium—Pruritus—Sorafenib—liver cancer	0.00365	0.00365	CcSEcCtD
Trospium—Dry skin—Epirubicin—liver cancer	0.00356	0.00356	CcSEcCtD
Trospium—Abdominal pain upper—Epirubicin—liver cancer	0.00355	0.00355	CcSEcCtD
Trospium—Orthostatic hypotension—Epirubicin—liver cancer	0.00355	0.00355	CcSEcCtD
Trospium—Migraine—Doxorubicin—liver cancer	0.00354	0.00354	CcSEcCtD
Trospium—Breast disorder—Epirubicin—liver cancer	0.00351	0.00351	CcSEcCtD
Trospium—Nasopharyngitis—Epirubicin—liver cancer	0.00347	0.00347	CcSEcCtD
Trospium—Gastritis—Epirubicin—liver cancer	0.00344	0.00344	CcSEcCtD
Trospium—Dizziness—Sorafenib—liver cancer	0.00341	0.00341	CcSEcCtD
Trospium—Abdominal distension—Epirubicin—liver cancer	0.00338	0.00338	CcSEcCtD
Trospium—Influenza—Epirubicin—liver cancer	0.00336	0.00336	CcSEcCtD
Trospium—Dry skin—Doxorubicin—liver cancer	0.00329	0.00329	CcSEcCtD
Trospium—Vomiting—Sorafenib—liver cancer	0.00328	0.00328	CcSEcCtD
Trospium—Orthostatic hypotension—Doxorubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Trospium—Abdominal pain upper—Doxorubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Trospium—Angina pectoris—Epirubicin—liver cancer	0.00327	0.00327	CcSEcCtD
Trospium—Rash—Sorafenib—liver cancer	0.00326	0.00326	CcSEcCtD
Trospium—Dermatitis—Sorafenib—liver cancer	0.00325	0.00325	CcSEcCtD
Trospium—Breast disorder—Doxorubicin—liver cancer	0.00325	0.00325	CcSEcCtD
Trospium—Headache—Sorafenib—liver cancer	0.00324	0.00324	CcSEcCtD
Trospium—Nasopharyngitis—Doxorubicin—liver cancer	0.00321	0.00321	CcSEcCtD
Trospium—Gastritis—Doxorubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Trospium—Dysuria—Epirubicin—liver cancer	0.00314	0.00314	CcSEcCtD
Trospium—Abdominal distension—Doxorubicin—liver cancer	0.00313	0.00313	CcSEcCtD
Trospium—Influenza—Doxorubicin—liver cancer	0.00311	0.00311	CcSEcCtD
Trospium—Pollakiuria—Epirubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Trospium—Nausea—Sorafenib—liver cancer	0.00307	0.00307	CcSEcCtD
Trospium—Photosensitivity reaction—Epirubicin—liver cancer	0.00306	0.00306	CcSEcCtD
Trospium—Weight increased—Epirubicin—liver cancer	0.00305	0.00305	CcSEcCtD
Trospium—Angina pectoris—Doxorubicin—liver cancer	0.00302	0.00302	CcSEcCtD
Trospium—Infestation NOS—Epirubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Trospium—Infestation—Epirubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00297	0.00297	CcSEcCtD
Trospium—Stomatitis—Epirubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Trospium—Urinary tract infection—Epirubicin—liver cancer	0.00291	0.00291	CcSEcCtD
Trospium—Dysuria—Doxorubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Trospium—Pollakiuria—Doxorubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Trospium—Haematuria—Epirubicin—liver cancer	0.00285	0.00285	CcSEcCtD
Trospium—Photosensitivity reaction—Doxorubicin—liver cancer	0.00283	0.00283	CcSEcCtD
Trospium—Weight increased—Doxorubicin—liver cancer	0.00283	0.00283	CcSEcCtD
Trospium—Infestation NOS—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Trospium—Infestation—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00275	0.00275	CcSEcCtD
Trospium—Stomatitis—Doxorubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Trospium—Rhinitis—Epirubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Trospium—Urinary tract infection—Doxorubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Trospium—Urinary tract disorder—Epirubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Trospium—Oedema peripheral—Epirubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Trospium—Haematuria—Doxorubicin—liver cancer	0.00264	0.00264	CcSEcCtD
Trospium—Connective tissue disorder—Epirubicin—liver cancer	0.00264	0.00264	CcSEcCtD
Trospium—Urethral disorder—Epirubicin—liver cancer	0.00263	0.00263	CcSEcCtD
Trospium—Visual impairment—Epirubicin—liver cancer	0.00259	0.00259	CcSEcCtD
Trospium—Erythema multiforme—Epirubicin—liver cancer	0.00254	0.00254	CcSEcCtD
Trospium—Eye disorder—Epirubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Trospium—Flushing—Epirubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Trospium—Cardiac disorder—Epirubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Trospium—Rhinitis—Doxorubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Trospium—Urinary tract disorder—Doxorubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Trospium—Oedema peripheral—Doxorubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Trospium—Connective tissue disorder—Doxorubicin—liver cancer	0.00244	0.00244	CcSEcCtD
Trospium—Angiopathy—Epirubicin—liver cancer	0.00244	0.00244	CcSEcCtD
Trospium—Urethral disorder—Doxorubicin—liver cancer	0.00244	0.00244	CcSEcCtD
Trospium—Mediastinal disorder—Epirubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Trospium—Visual impairment—Doxorubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Trospium—Erythema multiforme—Doxorubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Trospium—Malnutrition—Epirubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Trospium—Eye disorder—Doxorubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Trospium—Cardiac disorder—Doxorubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Trospium—Flushing—Doxorubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Trospium—Flatulence—Epirubicin—liver cancer	0.0023	0.0023	CcSEcCtD
Trospium—Dysgeusia—Epirubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Trospium—Back pain—Epirubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Trospium—Angiopathy—Doxorubicin—liver cancer	0.00226	0.00226	CcSEcCtD
Trospium—Muscle spasms—Epirubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Trospium—Mediastinal disorder—Doxorubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Trospium—Vision blurred—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Trospium—Malnutrition—Doxorubicin—liver cancer	0.00216	0.00216	CcSEcCtD
Trospium—Flatulence—Doxorubicin—liver cancer	0.00213	0.00213	CcSEcCtD
Trospium—Dysgeusia—Doxorubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Trospium—Syncope—Epirubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Trospium—Back pain—Doxorubicin—liver cancer	0.00209	0.00209	CcSEcCtD
Trospium—Muscle spasms—Doxorubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Trospium—Palpitations—Epirubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Trospium—Loss of consciousness—Epirubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Trospium—Vision blurred—Doxorubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Trospium—Chest pain—Epirubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00198	0.00198	CcSEcCtD
Trospium—Dry mouth—Epirubicin—liver cancer	0.00195	0.00195	CcSEcCtD
Trospium—Syncope—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Trospium—Confusional state—Epirubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Trospium—Palpitations—Doxorubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Trospium—Anaphylactic shock—Epirubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Trospium—Oedema—Epirubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Trospium—Loss of consciousness—Doxorubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Trospium—Infection—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Trospium—Shock—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Trospium—Nervous system disorder—Epirubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Trospium—Tachycardia—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Trospium—Skin disorder—Epirubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Trospium—Hyperhidrosis—Epirubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Trospium—Chest pain—Doxorubicin—liver cancer	0.00184	0.00184	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Trospium—Dry mouth—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Trospium—Confusional state—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Trospium—Anaphylactic shock—Doxorubicin—liver cancer	0.00177	0.00177	CcSEcCtD
Trospium—Oedema—Doxorubicin—liver cancer	0.00177	0.00177	CcSEcCtD
Trospium—Infection—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Trospium—Shock—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Trospium—Nervous system disorder—Doxorubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Trospium—Tachycardia—Doxorubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Trospium—Skin disorder—Doxorubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Trospium—Hyperhidrosis—Doxorubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Trospium—Somnolence—Epirubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Trospium—Dyspepsia—Epirubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Trospium—Decreased appetite—Epirubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Trospium—Gastrointestinal disorder—Epirubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Trospium—Fatigue—Epirubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Trospium—Constipation—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Trospium—Feeling abnormal—Epirubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Trospium—Somnolence—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Trospium—Gastrointestinal pain—Epirubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Trospium—Dyspepsia—Doxorubicin—liver cancer	0.00155	0.00155	CcSEcCtD
Trospium—Decreased appetite—Doxorubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Trospium—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Trospium—Fatigue—Doxorubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Trospium—Urticaria—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Trospium—Constipation—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Trospium—Abdominal pain—Epirubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Trospium—Feeling abnormal—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Trospium—Gastrointestinal pain—Doxorubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Trospium—Urticaria—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Trospium—Abdominal pain—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Trospium—Asthenia—Epirubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Trospium—Pruritus—Epirubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Trospium—Asthenia—Doxorubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Trospium—Dizziness—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Trospium—Pruritus—Doxorubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Trospium—Vomiting—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Trospium—Rash—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Trospium—Dermatitis—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Trospium—Headache—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Trospium—Dizziness—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Trospium—Nausea—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Trospium—Vomiting—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Trospium—Rash—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Trospium—Dermatitis—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Trospium—Headache—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Trospium—Nausea—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
